Avalon GloboCare Corp. Files 8-K Report

Ticker: ALBT · Form: 8-K · Filed: Oct 9, 2024 · CIK: 1630212

Sentiment: neutral

Topics: 8-K, financial-statements, exhibits

TL;DR

Avalon GloboCare filed an 8-K with financial updates and Reg FD disclosure.

AI Summary

On October 9, 2024, Avalon GloboCare Corp. filed an 8-K report. The filing primarily concerns financial statements and exhibits, as well as a Regulation FD disclosure. No specific new material events or financial figures were detailed in the provided excerpt.

Why It Matters

This filing indicates that Avalon GloboCare Corp. is providing updated financial statements and exhibits, which are crucial for investors to assess the company's financial health and performance.

Risk Assessment

Risk Level: low — The filing is a routine 8-K report for financial statements and exhibits, with no immediate indication of significant negative or positive events.

Key Players & Entities

FAQ

What specific financial statements or exhibits are being filed with this 8-K?

The provided excerpt states that the filing includes 'Financial Statements and Exhibits' but does not specify which ones.

What is the primary purpose of this 8-K filing for Avalon GloboCare Corp. on October 9, 2024?

The filing is a Current Report on Form 8-K, primarily for Regulation FD Disclosure and to report Financial Statements and Exhibits.

Where are Avalon GloboCare Corp.'s principal executive offices located?

The principal executive offices are located at 4400 Route 9 South, Suite 3100, Freehold, NJ 07728.

What is Avalon GloboCare Corp.'s state of incorporation?

Avalon GloboCare Corp. is incorporated in Delaware.

What is the Commission File Number for Avalon GloboCare Corp.?

The Commission File Number for Avalon GloboCare Corp. is 001-38728.

Filing Stats: 558 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-10-09 09:00:27

Key Financial Figures

Filing Documents

01. Financial Statement and Exhibits

Item 9.01. Financial Statement and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release of the Company dated October 9, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVALON GLOBOCARE CORP. Dated: October 9, 2024 By: /s/ Luisa Ingargiola Name: Luisa Ingargiola Title: Chief Financial Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing